Quipt Home Medical demonstrated important strategic expansions and maintained a steady adjusted EBITDA margin, indicating resilience and potential for future growth. However, there were declines in revenue year-over-year, a decrease in the customer base, and increased operating expenses, which highlight some ongoing challenges.

Company Guidance

During the third quarter of fiscal year 2025, Quipt Home Medical Corp. reported a return to positive organic growth and revenue stabilization. The company achieved $58.3 million in revenue, reflecting a 1.6% quarter-over-quarter increase, though it was a 4.1% decrease from the previous year's quarter. Adjusted EBITDA margin was consistent at 23.5%, with adjusted EBITDA totaling $13.7 million. Despite a net loss of $3 million or $0.07 per diluted share, cash flow from operations improved to $27.9 million for the nine months ended June 30, 2025. The company completed 210,000 unique setups/deliveries and maintained strong recurring revenue at 81% of total revenue. Quipt also announced a strategic joint venture with Hart Medical Equipment, enhancing their Midwest presence and projecting an annualized run rate revenue of roughly $300 million. This joint venture is expected to provide an immediate scale, with Hart generating approximately $60 million in revenue and $7 million in adjusted EBITDA as of June 30, 2025. The company's focus remains on operational excellence, with strategic expansions and partnerships set to drive long-term growth and shareholder value.

Revenue Stabilization and Organic Growth

Revenue for fiscal Q3 2025 was $58.3 million, a return to positive quarter-over-quarter organic growth of 1.6%, compared to $57.4 million in Q2 2025.

Strategic Health System Partnerships

Quipt announced partnerships with major health systems including Ballad Health and a joint venture with Henry Ford Health, McLaren Health, and Blanchard Valley Health, expanding presence into Michigan and Ohio.

Consistent Adjusted EBITDA Margin

Adjusted EBITDA margin remained steady at 23.5% in Q3 2025, showing consistent performance despite a dynamic environment.

Expansion and Infrastructure Growth

With over 160 locations across 27 states, Quipt serves over 325,000 active patients, supporting scalability and efficiency.

Strong Recurring Revenue

Recurring revenue for Q3 2025 was robust at 81% of total revenue, indicating a stable revenue stream.

Joint Venture with Hart Medical Equipment

The joint venture adds immediate scale with Hart generating approximately $60 million in revenue and $7 million in adjusted EBITDA.

Quipt Home Medical (TSE:QIPT) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

TSE:QIPT Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Dec 22, 2025	2025 (Q4)	-0.04 / -	-0.11	―	―	―
Aug 11, 2025	2025 (Q3)	-0.09 / -0.10	-0.055	-75.00% (-0.04)	―	―
May 12, 2025	2025 (Q2)	-0.02 / -0.10	-0.041	-133.33% (-0.06)	―	―
Feb 10, 2025	2025 (Q1)	-0.06 / -0.04	-0.014	-200.00% (-0.03)	―	―
Dec 16, 2024	2024 (Q4)	-0.02 / -0.11	-0.041	-166.67% (-0.07)	―	―
Aug 14, 2024	2024 (Q3)	-0.01 / -0.06	-0.041	-33.33% (-0.01)	―	―
May 15, 2024	2024 (Q2)	<0.01 / -0.04	-0.028	-50.00% (-0.01)	―	―
Feb 14, 2024	2024 (Q1)	-0.02 / -0.01	0.014	-200.00% (-0.03)	―	―
Dec 18, 2023	2023 (Q4)	>-0.01 / -0.04	0.069	-160.00% (-0.11)	―	―
Aug 14, 2023	2023 (Q3)	>-0.01 / -0.04	0	―	―	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

TSE:QIPT Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Aug 11, 2025	C$2.92	C$2.72	-6.85%
May 12, 2025	C$2.98	C$2.30	-22.82%
Feb 10, 2025	C$4.33	C$4.21	-2.77%
Dec 16, 2024	C$4.38	C$3.72	-15.07%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Quipt Home Medical (TSE:QIPT) report earnings?

Quipt Home Medical (TSE:QIPT) is schdueled to report earning on Dec 22, 2025, TBA (Confirmed).

What is Quipt Home Medical (TSE:QIPT) earnings time?

Quipt Home Medical (TSE:QIPT) earnings time is at Dec 22, 2025, TBA (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is TSE:QIPT EPS forecast?

TSE:QIPT EPS forecast for the fiscal quarter 2025 (Q4) is -0.04.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing